These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3874720)

  • 21. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
    Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
    Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
    Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
    Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A human leukemia cell culture system for testing new antifols: differential sensitivity of lymphoid and nonlymphoid cell lines to unconjugated and methotrexate-conjugated polymers of basic amino acids.
    McGuire JJ; Russell CA
    Leukemia; 1990 Jan; 4(1):48-52. PubMed ID: 2296201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
    McGuire JJ; Haile WH; Yeh CC
    Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-resistance studies of folylpolyglutamate synthetase-deficient, methotrexate-resistant CCRF-CEM human leukemia sublines.
    McGuire JJ; Heitzman KJ; Haile WH; Russell CA; McCloskey DE; Piper JR
    Leukemia; 1993 Dec; 7(12):1996-2003. PubMed ID: 8255099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
    Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
    Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines.
    McGuire JJ; Magee KJ; Russell CA; Canestrari JM
    Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells.
    Romanini A; Li WW; Colofiore JR; Bertino JR
    J Natl Cancer Inst; 1992 Jul; 84(13):1033-8. PubMed ID: 1376779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of folic acid exporter function with markedly augmented folate accumulation in lipophilic antifolate-resistant mammalian cells.
    Assaraf YG; Goldman ID
    J Biol Chem; 1997 Jul; 272(28):17460-6. PubMed ID: 9211890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the effect of AG337, a novel lipophilic thymidylate synthase inhibitor, on human head and neck and human leukemia cell lines.
    McGuire JJ; Canestrari JG; Nagel GS
    Int J Oncol; 1999 Dec; 15(6):1245-50. PubMed ID: 10568835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leucovorin rescue of human cancer and bone marrow cells following edatrexate or methotrexate.
    Jolivet J; Jansen G; Peters GJ; Pinard MF; Schornagel JH
    Biochem Pharmacol; 1994 Feb; 47(4):659-65. PubMed ID: 7510479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells.
    Zhao R; Gao F; Goldman ID
    Biochem Pharmacol; 2001 Apr; 61(7):857-65. PubMed ID: 11274972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of variant dihydrofolate reductase with decreased binding affinity to antifolates in MOLT-3 human leukemia cell lines resistant to trimetrexate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Cancer Lett; 1995 Jan; 88(1):93-9. PubMed ID: 7850779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
    Goldman ID; Matherly LH
    NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection.
    Lacerda JF; Göker E; Kheradpour A; Dennig D; Elisseyeff Y; Jagiello C; O'Reilly RJ; Bertino JR
    Blood; 1995 May; 85(10):2675-9. PubMed ID: 7742525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.
    Zeng H; Chen ZS; Belinsky MG; Rea PA; Kruh GD
    Cancer Res; 2001 Oct; 61(19):7225-32. PubMed ID: 11585759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological properties of fluoroglutamate-containing analogs of folates and methotrexate with altered capacities to form poly (gamma-glutamate) metabolites.
    McGuire JJ; Hart BP; Haile WH; Magee KJ; Rhee M; Bolanowska WE; Russell C; Galivan J; Paul B; Coward JK
    Biochem Pharmacol; 1996 Oct; 52(8):1295-303. PubMed ID: 8937438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.